OpenBilldrug price receipt

NADAC week of 2026-10-14

ENTECAVIR 0.5 MG TABLET

For 30 tablets

Pharmacies pay

$6.56 filed

30 × $0.21857 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: The Part D file flags this drug’s average spending per dosage unit as an outlier, so OpenBill does not use it as a reference price. Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$12.54 estimated

$6.56 + $0.98 (15%) + $5.00 fee per fill = $12.54

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

ENTECAVIR 0.5 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “entecavir” and “entecavir anhydrous”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.

FDA lists 10 labelers (the companies named on the label) for its NDCs, among them NorthStar RxLLC, Camber Pharmaceuticals, Inc. and Cameron Pharmaceuticals.

FDA’s Established Pharmacologic Class for it is Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor.

The NADAC file of 2026-10-14 prices it under 13 NDCs (National Drug Codes); the FDA directory lists 12 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $6.56 for 30 tablets (30 × $0.21857 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 10 labelers

LabelerNDCsPharmacies pay per unit
Camber Pharmaceuticals, Inc.2$0.21857 per EA filed
EPIC PHARMA, LLC2$0.21857 per EA filed
American Health Packaging1$0.21857 per EA filed
Aurobindo Pharma Limited1$0.21857 per EA filed
Cameron Pharmaceuticals1$0.21857 per EA filed
Carlsbad Technology, Inc.1$0.21857 per EA filed
Cipla USA Inc.1$0.21857 per EA filed
NorthStar RxLLC1$0.21857 per EA filed
Solco Healthcare LLC1$0.21857 per EA filed
Zydus Pharmaceuticals USA Inc.1$0.21857 per EA filed
Not listed as a package in the FDA directory1$0.21857 per EA filed
All 13 NDCs, with labeler and price
  • 16714-0717-01 · NorthStar RxLLC · $0.21857 per EA · eff. 2026-09-23 filed
  • 31722-0833-30 · Camber Pharmaceuticals, Inc. · $0.21857 per EA · eff. 2026-09-23 filed
  • 31722-0833-90 · Camber Pharmaceuticals, Inc. · $0.21857 per EA · eff. 2026-09-23 filed
  • 42494-0457-30 · Cameron Pharmaceuticals · $0.21857 per EA · eff. 2026-09-23 filed
  • 42806-0658-30 · EPIC PHARMA, LLC · $0.21857 per EA · eff. 2026-09-23 filed
  • 42806-0667-30 · Epic Pharma, LLC · $0.21857 per EA · eff. 2026-09-23 filed
  • 43547-0436-03 · Solco Healthcare LLC · $0.21857 per EA · eff. 2026-09-23 filed
  • 60687-0216-25 · American Health Packaging · $0.21857 per EA · eff. 2026-09-23 filed
  • 60687-0216-95 · not listed as a package in the FDA directory · $0.21857 per EA · eff. 2026-09-23 filed
  • 61442-0311-30 · Carlsbad Technology, Inc. · $0.21857 per EA · eff. 2026-09-23 filed
  • 65862-0841-30 · Aurobindo Pharma Limited · $0.21857 per EA · eff. 2026-09-23 filed
  • 68382-0920-06 · Zydus Pharmaceuticals USA Inc. · $0.21857 per EA · eff. 2026-09-23 filed
  • 69097-0426-02 · Cipla USA Inc. · $0.21857 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

2 other products in the NADAC file share an FDA nonproprietary name with ENTECAVIR 0.5 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
BARACLUDE 0.5 MG TABLET
brand · tablet, film coated
$44.18654 per EA filed
eff. 2025-11-19
$31.28299 per EA filed
Part D 2024 average
ENTECAVIR 0.5 MG TABLET this page
generic · tablet, film coated / tablet
$0.21857 per EA filed
eff. 2026-09-23
We don’t know yet
ENTECAVIR 1 MG TABLET
generic · tablet, film coated / tablet
$0.36844 per EA filed
eff. 2026-09-23
We don’t know yet

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2025-11-19, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 13 NDCs’ NADAC prices is $0.21857 per EA filed.

Of the 28 other products in FDA’s Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor class priced per EA, 28 have a higher middle NADAC price and 0 a lower one. The one in the middle is VEMLIDY 25 MG TABLET, at $51.98384 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.